Article Details
Retrieved on: 2024-05-24 15:59:07
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
“For more than two decades, omalizumab, a blockbuster monoclonal antibody anti-IgE, has revolutionised the management of chronic immune-mediated ...
Article found on: pipelinereview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here